What is Calavo Growers Inc's earnings per share (EPS)?

Calavo Growers Inc (CVGW) reported diluted earnings per share of $1.11 for fiscal year 2025. This represents a 1950.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Calavo Growers Inc (CVGW) Financials

CVGW

Trailing 12 months to January 31, 2026

Revenue $616.3M -10.5% YoY

Net Income $16.1M +67.7% YoY

EPS (Diluted) $0.90 +66.7% YoY

Free Cash Flow $14.7M -17.6% YoY

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Jan 31, 2026 Reported Mar 12, 2026 Currency USD FYE October

Newest figures come from the 10-Q for Q1 FY2026, filed Mar 12, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CVGW SEC filings page.

Calavo Growers Inc (CVGW) reported $616.3M in revenue over the twelve months to Jan 31, 2026, down 10.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CVGW FY2025 2026-08-30

Calavo Growers’ recent earnings shift reflects cost discipline and balance-sheet strengthening more than top-line expansion

The key change is that FY2025 net income of $19.8M was broadly matched by operating cash flow of $21.5M, making the earnings rebound operationally tangible. With free cash flow at $19.4M after reinvestment, cash conversion supports the conclusion that FY2025 profit was not merely an accounting rebound, unlike the prior loss years.

Operating margin reached 3.0% in FY2025 from 2.5% in FY2024 despite lower revenue, so profitability improved without relying on sales expansion. SG&A fell to $42.1M, indicating cost discipline—rather than a proven price effect—was the clearest support for the margin step-up.

Total liabilities fell to $85.3M while current ratio rose to 2.5x, indicating a less creditor-dependent balance-sheet posture. Capital expenditures of $2.2M were modest beside $19.4M of free cash flow, so FY2025 cash generation required limited reinvestment; this is a one-year snapshot.

Financial Health Signals

Financial Health Score 51/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Calavo Growers Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Calavo Growers Inc has an operating margin of 3.0%, meaning the company retains $3 of operating profit per $100 of revenue. This results in a moderate score of 41/100, indicating healthy but not exceptional operating efficiency. This is up from 2.5% the prior year.

Growth

Calavo Growers Inc's revenue declined 2.0% year-over-year, from $661.5M to $648.4M. This contraction results in a growth score of 48/100.

Leverage

Calavo Growers Inc has a moderate D/E ratio of 0.41. This balance of debt and equity financing earns a leverage score of 64/100.

Liquidity

With a current ratio of 2.47, Calavo Growers Inc holds $2.47 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 70/100.

Cash Flow

Calavo Growers Inc has a free cash flow margin of 3.0%, earning a moderate score of 31/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Calavo Growers Inc's ROE of 9.6% shows moderate profitability relative to equity, earning a score of 49/100. This is up from -0.5% the prior year.

Altman Z-Score Safe

6.22

Calavo Growers Inc scores 6.22, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($466.3M) relative to total liabilities ($85.3M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

6/8

Calavo Growers Inc passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.09x

For every $1 of reported earnings, Calavo Growers Inc generates $1.09 in operating cash flow ($21.5M OCF vs $19.8M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

23.71x

Calavo Growers Inc earns $23.71 in operating income for every $1 of interest expense ($19.6M vs $827K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$122.2M

YoY-20.8%

QoQ-2.0%

Calavo Growers Inc generated $122.2M in revenue in Q1 2026. This represents a decrease of 20.8% from the same quarter a year earlier. Against the prior quarter it is down 2.0%.

EBITDA

$307K

YoY-95.6%

QoQ+198.1%

Calavo Growers Inc's EBITDA was $307K in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 95.6% from the same quarter a year earlier. Against the prior quarter it is up 198.1%.

Net Income

$732K

YoY-83.4%

QoQ-80.8%

Calavo Growers Inc reported $732K in net income in Q1 2026. This represents a decrease of 83.4% from the same quarter a year earlier. Against the prior quarter it is down 80.8%.

EPS (Diluted)

$0.04

YoY-84.0%

QoQ-81.8%

5Y CAGR-33.2%

10Y CAGR-19.9%

Calavo Growers Inc earned $0.04 per diluted share (EPS) in Q1 2026. This represents a decrease of 84.0% from the same quarter a year earlier. Against the prior quarter it is down 81.8%.

Cash & Balance Sheet

Free Cash Flow

-$9.4M

YoY-100.6%

QoQ-872.4%

Calavo Growers Inc recorded an outflow of $9.4M in free cash flow in Q1 2026, representing a cash shortfall after capex. This represents a decrease of 100.6% from the same quarter a year earlier. Against the prior quarter it is down 872.4%.

Cash & Debt

$47.7M

YoY-1.7%

QoQ-22.1%

5Y CAGR+42.3%

10Y CAGR+19.3%

Calavo Growers Inc held $47.7M in cash as of Q1 2026; long-term debt is not reported for that period.

Dividends Per Share

$0.20

YoY0.0%

Calavo Growers Inc paid $0.20 per share in dividends in Q1 2026. That is unchanged from the same quarter a year earlier.

Shares Outstanding

18M

YoY+0.2%

QoQ0.0%

5Y CAGR+0.2%

10Y CAGR+0.2%

Calavo Growers Inc had 18M shares outstanding in Q1 2026. This represents an increase of 0.2% from the same quarter a year earlier. It is unchanged from the prior quarter.

Margins & Returns

Gross Margin

12.4%

YoY+2.2pp

QoQ+3.1pp

Calavo Growers Inc's gross margin was 12.4% in Q1 2026, indicating the percentage of revenue retained after direct costs. This is up 2.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.1 percentage points.

Operating Margin

-1.2%

YoY-4.5pp

QoQ+0.2pp

Calavo Growers Inc's operating margin was -1.2% in Q1 2026, reflecting core business profitability. This is down 4.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.

Net Margin

0.6%

YoY-2.3pp

QoQ-2.5pp

Calavo Growers Inc's net profit margin was 0.6% in Q1 2026, showing the share of revenue converted to profit. This is down 2.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.5 percentage points.

Return on Equity

0.4%

YoY-1.8pp

QoQ-1.5pp

Calavo Growers Inc's ROE was 0.4% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is down 1.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.5 percentage points.

Capital Allocation

Capital Expenditures

$788K

YoY+179.4%

QoQ-27.4%

5Y CAGR-30.2%

10Y CAGR-15.8%

Calavo Growers Inc invested $788K in capex in Q1 2026, funding long-term assets and infrastructure. This represents an increase of 179.4% from the same quarter a year earlier. Against the prior quarter it is down 27.4%.

R&D Spending

Not reported for Q1 2026.

Share Buybacks

Not reported for Q1 2026.

CVGW Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CVGW quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$616.3M	$648.4M-2.0%	$661.5M+11.4%	$594.1M-22.8%	$769.7M-27.1%	$1.1B-0.3%	$1.1B-11.4%	$1.2B+9.8%	$1.1B+1.2%	$1.1B+15.0%	$935.7M+9.2%	$856.8M+9.5%	$782.5M+13.2%	$691.5M+25.5%	$551.1M+5.5%	$522.5M
Cost of Revenue	$553.1M	$584.8M-1.5%	$593.7M+11.7%	$531.5M-25.7%	$714.9M-28.4%	$998.4M+3.0%	$969.5M-9.2%	$1.1B+9.5%	$975.1M+1.5%	$961.0M+16.0%	$828.1M+7.3%	$771.6M+8.5%	$711.3M+12.5%	$632.0M+28.9%	$490.5M+2.1%	$480.2M
Gross Profit	$63.1M	$63.7M-6.1%	$67.8M+8.3%	$62.6M+14.4%	$54.7M-4.7%	$57.4M-36.1%	$89.9M-29.8%	$128.1M+12.7%	$113.6M-0.8%	$114.5M+6.5%	$107.5M+26.2%	$85.2M+19.7%	$71.2M+19.8%	$59.4M-2.0%	$60.7M+43.4%	$42.3M
R&D Expenses	N/A	N/A	$100K0.0%	$100K0.0%	$100K-66.7%	$300K-57.1%	$700K	N/A	N/A	N/A	N/A	N/A	$800K-46.7%	$1.5M	N/A	N/A
SG&A Expenses	$48.2M	$42.1M-15.9%	$50.0M+5.8%	$47.3M+1.6%	$46.5M-17.6%	$56.5M-2.6%	$58.0M-2.0%	$59.1M+3.6%	$57.1M+0.8%	$56.7M+22.0%	$46.4M+11.7%	$41.6M+13.5%	$36.6M+9.3%	$33.5M+2.4%	$32.7M+36.4%	$24.0M
Operating Income	$13.1M	$19.6M+17.3%	$16.7M+37.0%	$12.2M+79.9%	$6.8M+167.9%	-$10.0M-131.1%	$32.2M-54.7%	$71.0M+25.7%	$56.5M-2.3%	$57.9M-5.2%	$61.1M+39.9%	$43.7M+365.3%	-$16.5M-138.4%	-$6.9M-127.2%	$25.4M+38.4%	$18.3M
EBITDA	N/A	$27.1M-0.8%	$27.3M-7.3%	$29.5M+26.2%	$23.4M+208.6%	$7.6M-84.3%	$48.3M-43.0%	$84.7M+21.7%	$69.6M+1.4%	$68.6M-1.9%	$69.9M+35.2%	$51.7M+642.4%	-$9.5M-1675.2%	-$537K-101.7%	$31.3M+38.1%	$22.7M
Interest Expense	$743K	$827K-71.4%	$2.9M+16.0%	$2.5M+48.0%	$1.7M+111.3%	$798K-9.0%	$877K-7.5%	$948K+14.1%	$831K-18.8%	$1.0M+35.3%	$756K-8.9%	$830K-15.6%	$983K-10.5%	$1.1M-4.7%	$1.2M+13.4%	$1.0M
Income Tax	$3.9M	$4.6M+99.8%	$2.3M-62.2%	$6.1M+94.2%	$3.2M-70.5%	$10.7M+350.4%	-$4.3M-133.3%	$12.9M+1.3%	$12.7M-37.8%	$20.4M-6.5%	$21.9M+35.9%	$16.1M+511.0%	-$3.9M+16.9%	-$4.7M-146.2%	$10.2M+40.9%	$7.2M
Net Income	$16.1M	$19.8M+1939.8%	-$1.1M+87.1%	-$8.3M-33.5%	-$6.2M+47.1%	-$11.8M+13.3%	-$13.6M-137.2%	$36.6M+13.5%	$32.3M-13.4%	$37.3M-2.0%	$38.0M+39.8%	$27.2M+27940.2%	$97K+105.4%	-$1.8M-111.4%	$15.8M+42.8%	$11.1M
EPS (Basic)	N/A	$1.11+1950.0%	-$0.06+87.2%	-$0.47-34.3%	-$0.35+47.8%	-$0.67+14.1%	-$0.78-137.3%	$2.09+13.0%	$1.85-13.6%	$2.14-2.3%	$2.19+39.5%	$1.57+15600.0%	$0.01+108.3%	-$0.12-111.2%	$1.07+42.7%	$0.75
EPS (Diluted)	$0.90	$1.11+1950.0%	-$0.06+87.2%	-$0.47-34.3%	-$0.35+47.8%	-$0.67+14.1%	-$0.78-137.5%	$2.08+13.0%	$1.84-13.6%	$2.13-2.3%	$2.18+38.9%	$1.57	$0.01	-$0.12-111.4%	$1.05+40.0%	$0.75
Diluted Shares (Avg)	N/A	18M+0.2%	18M+0.1%	18M+0.6%	18M+0.7%	18M+0.3%	18M-0.2%	18M+0.1%	18M+0.3%	18M+0.5%	17M+0.4%	17M	17M	15M-1.6%	15M+2.4%	15M

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Revenue	$122.2M-20.8%	$124.7M-26.6%	$178.8M-0.4%	$190.5M+3.3%	$154.4M+21.0%	$170.0M+19.5%	$179.6M+11.7%	$184.4M+16.5%
Cost of Revenue	$107.0M-22.8%	$113.0M-26.4%	$160.6M+0.7%	$172.5M+5.3%	$138.7M+18.7%	$153.5M+17.8%	$159.5M+14.9%	$163.8M+14.9%
Gross Profit	$15.2M-3.5%	$11.6M-29.0%	$18.2M-9.4%	$18.1M-11.9%	$15.7M+46.2%	$16.4M+38.5%	$20.1M-8.7%	$20.5M+31.1%
SG&A Expenses	$16.4M+59.4%	$12.3M-6.0%	$9.2M-12.2%	$10.3M-20.9%	$10.3M-23.6%	$13.0M+40.6%	$10.5M-19.1%	$13.0M-2.6%
Operating Income	-$1.4M-128.7%	-$1.7M-155.0%	$8.7M-7.5%	$7.6M+4.3%	$5.0M+263.5%	$3.1M+363.8%	$9.4M-8.4%	$7.3M+280.2%
EBITDA	$307K-95.6%	$103K-98.0%	$10.5M-7.8%	$9.5M+1.0%	$7.0M+375.7%	$5.1M-1.6%	$11.4M-21.8%	$9.4M+51.2%
Interest Expense	$129K-39.4%	$211K-23.0%	$199K-76.1%	$204K-78.8%	$213K-74.2%	$274K-74.7%	$833K+5.0%	$962K+294.3%
Income Tax	$473K-62.3%	-$952K-134.0%	$1.8M+225.4%	$2.5M+550.3%	$1.3M+119.0%	$2.8M-15.0%	-$1.4M-159.8%	$390K-19.4%
Net Income	$732K-83.4%	$3.8M+2846.0%	$4.7M+744.0%	$6.8M+13.0%	$4.4M+170.4%	-$139K+98.2%	-$732K-111.0%	$6.1M+251.7%
EPS (Basic)	$0.04-84.0%	$0.21+2200.0%	$0.26+750.0%	$0.38+11.8%	$0.25+171.4%	-$0.01+97.8%	-$0.04-110.8%	$0.34+247.8%
EPS (Diluted)	$0.04-84.0%	$0.22+2300.0%	$0.26+750.0%	$0.38+11.8%	$0.25+171.4%	-$0.01+97.8%	-$0.04-110.8%	$0.34+247.8%
Diluted Shares (Avg)	18M0.0%	N/A	18M+0.3%	18M-0.2%	18M+0.6%	N/A	18M-0.1%	18M-0.1%

Not reported in any period shown, so not listed: R&D Expenses.

CVGW Balance Sheet

CVGW quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$292.2M-2.9%	$301.1M-22.2%	$386.9M+0.3%	$385.7M-13.4%	$445.4M+3.7%	$429.6M+10.1%	$390.4M+6.2%	$367.7M+1.0%	$364.1M+11.0%	$327.9M+15.1%	$284.9M+0.5%	$283.5M+18.1%	$239.9M+15.4%	$207.9M+12.2%	$185.3M
Current Assets	$149.4M-5.8%	$158.6M+18.9%	$133.4M+6.1%	$125.7M-17.7%	$152.6M+12.3%	$135.9M+6.6%	$127.5M-0.8%	$128.5M+7.2%	$119.8M-11.2%	$135.0M+15.5%	$116.8M-5.1%	$123.0M+12.1%	$109.7M+31.5%	$83.5M+16.8%	$71.5M
Cash & Equivalents	$61.2M+7.2%	$57.0M+2627.5%	$2.1M+1.5%	$2.1M+9.3%	$1.9M-53.5%	$4.1M-49.1%	$8.0M+424.5%	$1.5M-77.1%	$6.6M0.0%	$6.6M-7.6%	$7.2M+6.3%	$6.7M-15.9%	$8.0M+12.9%	$7.1M+156.1%	$2.8M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$33.6M-1.6%	$34.2M+8.2%	$31.6M-18.7%	$38.8M-4.7%	$40.8M-2.5%	$41.8M+13.3%	$36.9M+5.3%	$35.0M+13.6%	$30.9M-3.1%	$31.8M+20.9%	$26.4M-14.9%	$31.0M+8.0%	$28.7M+24.9%	$22.9M+29.0%	$17.8M
Accounts Receivable	$31.6M-24.5%	$41.9M+23.6%	$33.9M-42.6%	$59.0M-25.2%	$78.9M+23.9%	$63.7M+0.4%	$63.4M-4.1%	$66.1M-5.2%	$69.8M-0.5%	$70.1M+19.6%	$58.6M+3.5%	$56.6M+2.8%	$55.1M+41.7%	$38.9M+7.7%	$36.1M
Long-Term Investments	$0	$0	$0	$0-100.0%	$27.1M+16.6%	$23.2M-26.9%	$31.7M-25.5%	$42.6M+5.6%	$40.4M+18.6%	$34.0M+24.2%	$27.4M-38.2%	$44.4M-2.6%	$45.5M+17.2%	$38.8M+29.5%	$30.0M
Goodwill	$10.2M0.0%	$10.2M0.0%	$10.2M-64.4%	$28.7M0.0%	$28.7M+0.3%	$28.6M+56.4%	$18.3M-0.2%	$18.3M+0.2%	$18.3M0.0%	$18.3M0.0%	$18.3M0.0%	$18.3M0.0%	$18.3M0.0%	$18.3M-0.5%	$18.3M
Total Liabilities	$85.3M-15.4%	$100.8M-42.9%	$176.6M+8.8%	$162.4M-25.7%	$218.5M+25.9%	$173.6M+66.2%	$104.5M+1.7%	$102.8M-14.3%	$120.0M+6.3%	$112.9M+14.0%	$99.0M-4.9%	$104.1M-13.9%	$120.8M+14.9%	$105.2M+9.9%	$95.7M
Current Liabilities	$60.5M-17.4%	$73.2M-10.4%	$81.7M-19.8%	$102.0M-11.1%	$114.6M+7.8%	$106.3M+17.3%	$90.6M-8.4%	$98.9M-14.8%	$116.2M+6.2%	$109.3M+11.7%	$97.9M-3.1%	$101.0M-10.6%	$113.0M+53.1%	$73.8M+17.5%	$62.8M
Non-Current Liabilities	$23.2M-11.2%	$26.1M-72.5%	$94.9M+57.0%	$60.4M-41.8%	$103.9M+54.4%	$67.3M+385.4%	$13.9M+261.6%	$3.8M+0.2%	$3.8M+39.1%	$2.8M+235.6%	$820K-70.6%	$2.8M-64.8%	$7.9M-66.6%	$23.7M-9.7%	$26.2M
Long-Term Debt	N/A	N/A	N/A	$4.4M-19.9%	$5.6M-2.9%	$5.7M+5.6%	$5.4M+1623.6%	$314K-28.5%	$439K-1.3%	$445K-24.1%	$586K-79.0%	$2.8M-64.2%	$7.8M-40.2%	$13.0M-28.5%	$18.2M
Total Equity	$206.9M+3.3%	$200.3M-4.7%	$210.2M-5.9%	$223.4M-1.5%	$226.9M-11.4%	$256.0M-10.4%	$285.9M+7.9%	$265.0M+8.5%	$244.1M+13.5%	$215.1M+15.6%	$186.0M+3.7%	$179.4M+50.6%	$119.1M+15.9%	$102.7M+14.6%	$89.6M
Retained Earnings	$27.8M+24.6%	$22.3M-30.9%	$32.3M-36.7%	$51.1M-10.9%	$57.4M-35.9%	$89.5M-27.0%	$122.6M+31.6%	$93.1M+18.8%	$78.4M+35.7%	$57.8M+62.9%	$35.5M+59.9%	$22.2M-36.7%	$35.1M-29.0%	$49.3M+17.8%	$41.9M

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Total Assets	$298.2M-0.2%	$292.2M-2.9%	$301.2M-21.2%	$321.5M-21.9%	$298.9M-24.3%	$301.1M-22.2%	$382.4M-7.8%	$411.4M+1.0%
Current Assets	$152.6M-3.5%	$149.4M-5.8%	$159.1M-33.2%	$180.3M-31.3%	$158.2M-35.6%	$158.6M+18.9%	$238.3M+58.5%	$262.3M+81.3%
Cash & Equivalents	$47.7M-1.7%	$61.2M+7.2%	$63.8M+5562.0%	$60.4M+1312.6%	$48.5M+757.0%	$57.0M+2627.5%	$1.1M-19.7%	$4.3M+1.8%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$37.8M-5.3%	$33.6M-1.6%	$30.3M-4.7%	$41.6M+0.2%	$39.9M+0.8%	$34.2M+8.2%	$31.8M-18.1%	$41.6M-3.0%
Accounts Receivable	$40.6M-13.9%	$31.6M-24.5%	$41.5M-20.0%	$57.6M+2.6%	$47.1M+33.9%	$41.9M+23.6%	$51.8M-32.2%	$56.1M-18.4%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$10.2M0.0%	$10.2M0.0%	$10.2M0.0%	$10.2M0.0%	$10.2M0.0%	$10.2M0.0%	$10.2M-64.4%	$10.2M-64.4%
Total Liabilities	$92.5M-3.7%	$85.3M-15.4%	$94.8M-46.5%	$114.9M-43.7%	$96.1M-50.0%	$100.8M-42.9%	$177.2M-9.5%	$204.0M+5.2%
Current Liabilities	$69.1M-2.4%	$60.5M-17.4%	$69.2M-40.6%	$90.2M-32.3%	$70.8M-41.4%	$73.2M-10.4%	$116.6M+15.1%	$133.2M+15.0%
Non-Current Liabilities	$21.8M-13.9%	$23.2M-11.2%	$24.0M-60.4%	$24.7M-65.1%	$25.3M-64.5%	$26.1M-72.5%	$60.7M-35.8%	$70.9M-9.4%
Total Equity	$205.7M+1.4%	$206.9M+3.3%	$206.4M+0.6%	$206.6M-0.4%	$202.9M+0.2%	$200.3M-4.7%	$205.2M-6.4%	$207.3M-2.7%
Retained Earnings	$25.0M+7.8%	$27.8M+24.6%	$27.6M+5.9%	$26.5M-7.4%	$23.2M-4.5%	$22.3M-30.9%	$26.1M-38.0%	$28.6M-23.1%

Not reported in any period shown, so not listed: Long-Term Debt.

CVGW Cash Flow Statement

CVGW quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$17.3M	$21.5M-11.8%	$24.4M+268.8%	-$14.5M-128.8%	$50.2M+270.1%	$13.6M-53.0%	$28.9M-59.9%	$72.1M+48.9%	$48.4M-22.1%	$62.1M+0.3%	$62.0M+66.2%	$37.3M+51.9%	$24.5M+78.9%	$13.7M-36.8%	$21.7M+176.2%	$7.9M
Depreciation & Amortization	N/A	$7.5M-29.4%	$10.6M-38.6%	$17.3M+4.2%	$16.6M-5.6%	$17.6M+9.2%	$16.1M+18.0%	$13.6M+4.5%	$13.0M+22.0%	$10.7M+21.3%	$8.8M+9.6%	$8.0M+16.1%	$6.9M+8.8%	$6.4M+7.8%	$5.9M+36.6%	$4.3M
Stock-Based Compensation	N/A	$1.2M-46.4%	$2.2M-58.5%	$5.2M+66.0%	$3.1M-20.5%	$4.0M-12.0%	$4.5M+24.9%	$3.6M-22.4%	$4.6M+7.2%	$4.3M+102.4%	$2.1M+1.2%	$2.1M+190.0%	$727K+93.4%	$376K-9.8%	$417K+121.8%	$188K
Capital Expenditures	$2.7M	$2.2M-25.6%	$2.9M-73.0%	$10.7M+9.5%	$9.8M-14.6%	$11.4M+0.8%	$11.3M-32.2%	$16.7M+11.4%	$15.0M-66.3%	$44.5M+103.6%	$21.9M+20.8%	$18.1M+55.9%	$11.6M+72.1%	$6.7M-12.9%	$7.7M+60.6%	$4.8M
Free Cash Flow	$14.7M	$19.4M-9.9%	$21.5M+185.6%	-$25.2M-162.2%	$40.5M+1796.2%	$2.1M-87.8%	$17.5M-68.3%	$55.4M+65.7%	$33.4M+89.6%	$17.6M-56.0%	$40.1M+109.1%	$19.2M+48.3%	$12.9M+85.4%	$7.0M-50.1%	$14.0M+359.7%	$3.0M
Investing Cash Flow	-$2.7M	-$2.2M-102.7%	$80.1M+849.1%	-$10.7M-223.2%	$8.7M+192.7%	-$9.4M+70.7%	-$31.9M-0.3%	-$31.9M-5.4%	-$30.2M+43.7%	-$53.7M-147.0%	-$21.7M-3.2%	-$21.1M	N/A	-$7.7M-8.2%	-$7.2M+65.7%	-$20.9M
Financing Cash Flow	-$15.5M	-$15.3M+69.7%	-$50.4M-302.4%	$24.9M+142.4%	-$58.6M-984.2%	-$5.4M-525.2%	-$865K+97.4%	-$33.8M-44.9%	-$23.3M-48.7%	-$15.7M+53.3%	-$33.6M-112.4%	-$15.8M	N/A	-$5.0M+50.6%	-$10.2M-169.4%	$14.8M
Dividends Paid	$14.3M	$14.3M+60.2%	$8.9M-14.5%	$10.4M-48.7%	$20.3M-0.1%	$20.3M+5.1%	$19.4M+10.2%	$17.6M+5.5%	$16.7M+6.1%	$15.7M+12.9%	$13.9M+7.2%	$13.0M+17.9%	$11.0M+14.1%	$9.6M+18.7%	$8.1M+0.3%	$8.1M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$4.8M	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Operating Cash Flow	-$8.7M-95.6%	$2.3M-78.7%	$8.0M-30.3%	$15.7M+650.0%	-$4.4M-7732.8%	$10.8M+129.0%	$11.4M+174.1%	$2.1M-0.3%
Depreciation & Amortization	$1.8M-9.7%	$1.8M-5.2%	$1.9M-9.2%	$1.9M-10.5%	$1.9M-57.4%	$1.9M-56.8%	$2.0M-53.2%	$2.1M-51.5%
Stock-Based Compensation	$1.8M+551.8%	N/A	N/A	N/A	$272K-71.1%	N/A	N/A	N/A
Capital Expenditures	$788K+179.4%	$1.1M+192.5%	$651K+358.5%	$133K-90.1%	$282K-72.6%	$371K-38.4%	$142K-91.3%	$1.3M-58.9%
Free Cash Flow	-$9.4M-100.6%	$1.2M-88.3%	$7.3M-35.2%	$15.6M+1988.3%	-$4.7M-384.5%	$10.5M+153.4%	$11.3M+166.2%	$745K+163.2%
Investing Cash Flow	-$788K-179.4%	-$1.1M-101.3%	-$651K-358.5%	-$133K+90.1%	-$282K+72.6%	$82.6M+13825.7%	-$142K+91.3%	-$1.3M+58.9%
Financing Cash Flow	-$4.0M-5.4%	-$3.8M+89.8%	-$3.9M+72.8%	-$3.7M-73.1%	-$3.8M-201.4%	-$37.6M-991.5%	-$14.4M-196.2%	-$2.1M-159.5%
Dividends Paid	$3.6M+0.3%	$3.6M-0.3%	$3.6M+100.9%	$3.6M+100.8%	$3.6M+100.3%	$3.6M+101.2%	$1.8M+0.1%	$1.8M+0.3%

Not reported in any period shown, so not listed: Share Buybacks.

CVGW Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CVGW quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	9.8%-0.4pp	10.3%-0.3pp	10.5%+3.4pp	7.1%+1.7pp	5.4%-3.1pp	8.5%-2.2pp	10.7%+0.3pp	10.4%-0.2pp	10.7%-0.8pp	11.5%+1.5pp	10.0%+0.9pp	9.1%+0.5pp	8.6%-2.4pp	11.0%+2.9pp	8.1%
Operating Margin	3.0%+0.5pp	2.5%+0.5pp	2.1%+1.2pp	0.9%+1.8pp	-0.9%-4.0pp	3.0%-2.9pp	5.9%+0.8pp	5.2%-0.2pp	5.4%-1.1pp	6.5%+1.4pp	5.1%+7.2pp	-2.1%-1.1pp	-1.0%-5.6pp	4.6%+1.1pp	3.5%
Net Margin	3.0%+3.2pp	-0.2%+1.2pp	-1.4%-0.6pp	-0.8%+0.3pp	-1.1%+0.2pp	-1.3%-4.3pp	3.1%+0.1pp	3.0%-0.5pp	3.5%-0.6pp	4.1%+0.9pp	3.2%+3.2pp	0.0%+0.3pp	-0.3%-3.1pp	2.9%+0.8pp	2.1%
Return on Equity	9.6%+10.1pp	-0.5%+3.4pp	-4.0%-1.2pp	-2.8%+2.4pp	-5.2%+0.1pp	-5.3%-18.1pp	12.8%+0.6pp	12.2%-3.1pp	15.3%-2.4pp	17.7%+3.1pp	14.6%+14.6pp	0.1%+1.6pp	-1.5%-16.9pp	15.4%+3.0pp	12.3%
Return on Assets	6.8%+7.1pp	-0.4%+1.8pp	-2.2%-0.5pp	-1.6%+1.0pp	-2.6%+0.5pp	-3.2%-12.6pp	9.4%+0.6pp	8.8%-1.5pp	10.2%-1.3pp	11.6%+2.0pp	9.6%+9.5pp	0.0%+0.8pp	-0.8%-8.3pp	7.6%+1.6pp	6.0%
Current Ratio	2.47+0.3x	2.17+0.5x	1.63+0.4x	1.23-0.1x	1.33+0.1x	1.28-0.1x	1.41+0.1x	1.30+0.3x	1.03-0.2x	1.230.0x	1.190.0x	1.22+0.2x	0.97-0.2x	1.130.0x	1.14
Debt-to-Equity	0.41-0.1x	0.50-0.3x	0.84+0.8x	0.020.0x	0.020.0x	0.020.0x	0.020.0x	0.000.0x	0.000.0x	0.000.0x	0.000.0x	0.020.0x	0.07-0.1x	0.13-0.1x	0.20
Asset Turnover	2.220.0x	2.20+0.7x	1.54-0.5x	2.00-0.4x	2.37-0.1x	2.47-0.6x	3.06+0.1x	2.960.0x	2.95+0.1x	2.85-0.2x	3.01+0.2x	2.76-0.1x	2.88+0.2x	2.65-0.2x	2.82
FCF Margin	3.0%-0.3pp	3.3%+7.5pp	-4.2%-9.5pp	5.3%+5.1pp	0.2%-1.5pp	1.7%-3.0pp	4.6%+1.6pp	3.1%+1.4pp	1.6%-2.6pp	4.3%+2.1pp	2.2%+0.6pp	1.7%+0.6pp	1.0%-1.5pp	2.5%+2.0pp	0.6%

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Gross Margin	12.4%+2.2pp	9.3%-0.3pp	10.2%-1.0pp	9.5%-1.7pp	10.2%+1.8pp	9.7%+1.3pp	11.2%-2.5pp	11.1%+1.2pp
Operating Margin	-1.2%-4.5pp	-1.4%-3.2pp	4.8%-0.4pp	4.0%0.0pp	3.3%+5.7pp	1.8%+1.4pp	5.2%-1.1pp	4.0%+2.7pp
Net Margin	0.6%-2.3pp	3.1%+3.1pp	2.6%+3.0pp	3.6%+0.3pp	2.9%+7.8pp	-0.1%+5.5pp	-0.4%-4.5pp	3.3%+5.8pp
Return on Equity	0.4%-1.8pp	1.8%+1.9pp	2.3%+2.6pp	3.3%+0.4pp	2.2%+5.3pp	-0.1%+3.7pp	-0.4%-3.4pp	2.9%+4.8pp
Return on Assets	0.3%-1.2pp	1.3%+1.4pp	1.6%+1.7pp	2.1%+0.7pp	1.5%+3.1pp	-0.1%+2.0pp	-0.2%-1.8pp	1.5%+2.5pp
Current Ratio	2.210.0x	2.47+0.3x	2.30+0.3x	2.000.0x	2.23+0.2x	2.17+0.5x	2.04+0.6x	1.97+0.7x
Debt-to-Equity	0.450.0x	0.41-0.1x	0.46-0.4x	0.56-0.4x	0.47-0.5x	0.50-0.3x	0.860.0x	0.98+1.0x
Asset Turnover	0.41-0.1x	0.43-0.1x	0.59+0.1x	0.59+0.1x	0.52+0.2x	0.56+0.2x	0.47+0.1x	0.45+0.1x
FCF Margin	-7.7%-4.7pp	1.0%-5.2pp	4.1%-2.2pp	8.2%+7.8pp	-3.0%-2.3pp	6.2%+3.3pp	6.3%+16.9pp	0.4%+1.1pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Calavo Growers Inc CVGW	FY2025	$648.4M	$19.8M	3.0%	$466.3M	51/100
Mission Produce, Inc. AVO	FY2025	$1.4B	$37.7M	2.7%	$1.2B	56/100
SpartanNash Company SPTN	FY2024	$9.5B	$299K	0.0%	$910.9M	37/100
Andersons Inc/The ANDE	FY2025	$11.0B	$95.7M	0.9%	$2.4B	23/100
United Natural Foods Inc UNFI	FY2025	$31.8B	-$118.0M	-0.4%	$2.7B	30/100
G Willi-Food International Ltd WILC	FY2025	$191.4M	$28.3M	14.8%	$397.2M	49/100

Where Calavo Growers Inc Ranks

Frequently Asked Questions

What is Calavo Growers Inc's annual revenue?

Calavo Growers Inc (CVGW) reported $648.4M in total revenue for fiscal year 2025. This represents a -2.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Calavo Growers Inc's revenue growing?

Calavo Growers Inc (CVGW) revenue declined by 2.0% year-over-year, from $661.5M to $648.4M in fiscal year 2025.

Is Calavo Growers Inc profitable?

Yes, Calavo Growers Inc (CVGW) reported a net income of $19.8M in fiscal year 2025, with a net profit margin of 3.0%.

What is Calavo Growers Inc's EBITDA?

Calavo Growers Inc (CVGW) had EBITDA of $27.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Calavo Growers Inc's gross margin?

Calavo Growers Inc (CVGW) had a gross margin of 9.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Calavo Growers Inc's operating margin?

Calavo Growers Inc (CVGW) had an operating margin of 3.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Calavo Growers Inc's net profit margin?

Calavo Growers Inc (CVGW) had a net profit margin of 3.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Calavo Growers Inc's return on equity (ROE)?

Calavo Growers Inc (CVGW) has a return on equity of 9.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Calavo Growers Inc's free cash flow?

Calavo Growers Inc (CVGW) generated $19.4M in free cash flow during fiscal year 2025. This represents a -9.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Calavo Growers Inc's operating cash flow?

Calavo Growers Inc (CVGW) generated $21.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Calavo Growers Inc's total assets?

Calavo Growers Inc (CVGW) had $292.2M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Calavo Growers Inc's capital expenditures?

Calavo Growers Inc (CVGW) invested $2.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does Calavo Growers Inc have outstanding?

Calavo Growers Inc (CVGW) had 18M shares outstanding as of fiscal year 2025.

What is Calavo Growers Inc's current ratio?

Calavo Growers Inc (CVGW) had a current ratio of 2.47 as of fiscal year 2025, which is generally considered healthy.

What is Calavo Growers Inc's debt-to-equity ratio?

Calavo Growers Inc (CVGW) had a debt-to-equity ratio of 0.41 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Calavo Growers Inc's return on assets (ROA)?

Calavo Growers Inc (CVGW) had a return on assets of 6.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Calavo Growers Inc's Altman Z-Score?

Calavo Growers Inc (CVGW) has an Altman Z-Score of 6.22, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Calavo Growers Inc's Piotroski F-Score?

Calavo Growers Inc (CVGW) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Calavo Growers Inc's earnings high quality?

Calavo Growers Inc (CVGW) has an earnings quality ratio of 1.09x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Calavo Growers Inc cover its interest payments?

Calavo Growers Inc (CVGW) has an interest coverage ratio of 23.71x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Calavo Growers Inc?

Calavo Growers Inc (CVGW) scores 51 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.